
|Articles|November 1, 2003
Facial Filler Study Shows Less is More
New Orleans - Calcium hydroxylapatite is similar to other dermal fillers in terms of efficacy and ease of administration, but less of it is necessary to get the job done, according to a Stanford University-based retrospective, prospective study. The study was performed by Hayes B. Gladstone, M.D., director, dermatologic surgery, Stanford University, Palo Alto, Calif., in conjunction with Mountain View, Calif., private practice dermatologic surgeon Greg S. Morganroth, M.D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
4
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
5














